Company
Oric Pharmaceuticals, Inc.
ORIC · CIK 0001796280
Acquisition (code M) of 600 shares at $4.36 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code M
Traded Sep 24, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001695028-26-000008 · filed 2026-09-25 · View filing →
Sale of 100 shares at $13.50 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 24, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001695028-26-000008 · filed 2026-09-25 · View filing →
Sale of 500 shares at $13.505 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 24, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001695028-26-000008 · filed 2026-09-25 · View filing →
Acquisition (code M) of 52,000 shares at $4.36 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code M
Traded Aug 26, 2026 · Disclosed Aug 28, 2026
Source: SEC Form 4 · 0001695028-26-000006 · filed 2026-08-28 · View filing →
Acquisition (code M) of 25,000 shares at $6 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code M
Traded Aug 26, 2026 · Disclosed Aug 28, 2026
Source: SEC Form 4 · 0001695028-26-000006 · filed 2026-08-28 · View filing →
Sale of 77,000 shares at $13.6859 per share.
Reporting Person Piscitelli Dominic · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 26, 2026 · Disclosed Aug 28, 2026
Source: SEC Form 4 · 0001695028-26-000006 · filed 2026-08-28 · View filing →